More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in 1962 while diligently searching for a safer…
Read More

More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in 1962 while diligently searching for a safer…
Read More
The biotech sector is experiencing a robust resurgence, marked by significant investment, strategic mergers and acquisitions, and groundbreaking clinical advancements,…
Read More
The medical community has long viewed glioblastoma multiforme (GBM) as a localized, albeit highly aggressive, malignancy confined within the blood-brain…
Read More
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in a quest for a safer anesthetic, the…
Read More
The global biotechnology sector is experiencing a significant resurgence, marked by robust investment, strategic mergers and acquisitions, and groundbreaking scientific…
Read More
A team of researchers at Monash University has unveiled a significant discovery that could redefine the therapeutic landscape for Alzheimer’s…
Read More
A groundbreaking study led by the University of California, Riverside (CA, USA) has demonstrated that a novel gene therapy successfully…
Read More
The intersection of metabolic health and cognitive function has emerged as one of the most critical frontiers in modern medicine,…
Read More
Chronic myeloid leukemia (CML), a malignancy of the white blood cells characterized by the presence of the Philadelphia chromosome, has…
Read More
In a landmark achievement for the field of hematology and regenerative medicine, scientists at the Indiana University School of Medicine…
Read More